KIN - Kindred Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,966---
Cost of Revenue324---
Gross Profit1,642---
Operating Expenses
Research Development26,39917,66513,86119,412
Selling General and Administrative26,49913,9888,3087,850
Non Recurring----
Total Operating Expenses53,22231,65322,16927,262
Operating Income or Loss-51,256-31,653-22,169-27,262
Income from Continuing Operations
Total Other Income/Expenses Net1,566774-330132
Earnings Before Interest and Taxes-51,256-31,653-22,169-27,262
Interest Expense----
Income Before Tax-49,690-30,879-22,499-27,130
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-49,690-30,879-22,499-27,130
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-49,690-30,879-22,499-27,130
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-49,690-30,879-22,499-27,130